News

News
September 01, 2026 • Sleep Review Magazine First Patient Dosed in Phase 2 Dose-Optimization Study for Novel OSA Drug

The clinical trial will evaluate an oral combination therapy to refine dosing ahead of a planned phase 3 development program for obstructive sleep apnea.

Read More
AASM seeks nominees for 2027 awards
September 01, 2026 • AASM AASM seeks nominees for 2027 awards

The AASM Awards Advisory Panel is now accepting nominations for the 2027 AASM awards, which recognize outstanding contributions to the field of sleep medicine. AASM members are invited to submit applications nominating i...

Read More
Montage 2026, issue three — Now available
August 31, 2026 • AASM Montage 2026, issue three — Now available

Each issue of Montage reflects the many ways sleep medicine continues to evolve — not only through new treatments and technologies, but through the day-to-day work of delivering patient-centered care. This issue explores...

Read More
Overview of FDA-approved hypoglossal nerve stimulation devices for obstructive sleep apnea
August 31, 2026 • AASM Overview of FDA-approved hypoglossal nerve stimulation devices for obstructive sleep apnea

By Samuel A. Collazo, MD; Thomas M. Kaffenberger, MD; and Ryan J. Soose, MD With the recent advent of Aura6000, there are now three Food and Drug Administration (FDA)- approved hypoglossal nerve stimulation (HGNS) device...

Read More
Coding Quarterly: TOMAC therapy for restless legs syndrome
August 31, 2026 • AASM Coding Quarterly: TOMAC therapy for restless legs syndrome

By the Coding and Reimbursement Advisory Committee Tonic motor activation (TOMAC), also known as bilateral peroneal nerve stimulation, is a therapeutic approach that delivers high-frequency electrical stimulation to the...

Read More
We must break through the iron gates to provide infusions for restless legs syndrome
August 31, 2026 • AASM We must break through the iron gates to provide infusions for restless legs syndrome

By J. Andrew Berkowski, MD Those afflicted by the often devastating sensorimotor sleep disorder of restless legs syndrome (RLS) continue to face obstacles in getting an otherwise obvious first-line treatment: intravenous...

Read More
News
August 31, 2026 • Sleep Review Magazine $75 Million Raised for AI-Powered Home Healthcare Platform Targeting Sleep Apnea

Happy Health has secured $75 million in funding to scale its AI-powered, home-based platform designed to diagnose obstructive sleep apnea in as few as three nights using an FDA-cleared smart ring.

Read More
Healthy sleep sets the stage for student success
August 28, 2026 • AASM Healthy sleep sets the stage for student success

To highlight the critical role healthy sleep plays in students’ learning, health, and well-being, the American Academy of Sleep Medicine is hosting its seventh annual Student Sleep Health Week, Sept. 14-18. This year’s t...

Read More
Survey finds many adults sacrifice sleep for school, work and family
August 28, 2026 • AASM Survey finds many adults sacrifice sleep for school, work and family

Getting enough sleep can take a back seat to the demands of work, school, and family life. According to a survey from the American Academy of Sleep Medicine, nearly one-third (32%) of American adults say work and school...

Read More
Mask selection for PAP therapy
August 28, 2026 • AASM Mask selection for PAP therapy

By Marta Kaminska, MD, MSc; David Zielinski, MD; and Veronique Adam, RRT The success of positive airway pressure (PAP) therapy, whether continuous positive airway pressure (CPAP) or noninvasive ventilation (NIV) via a bi...

Read More